SMURF1: a promising target for colon cancer therapy

Xiufang Xiong; Yongchao Zhao; Yi Sun

doi:10.1093/procel/pwae053

Protein Cell ›› 2025, Vol. 16 ›› Issue (3) : 157 -160. DOI: 10.1093/procel/pwae053

COMMENTARY

SMURF1: a promising target for colon cancer therapy

Xiufang Xiong ¹^,³
, Yongchao Zhao ²^,³^,^†
, Yi Sun ¹^,³^,^†

Author information +

History +

PDF (2026KB)

Cite this article

Download citation ▾

Xiufang Xiong, Yongchao Zhao, Yi Sun. SMURF1: a promising target for colon cancer therapy. Protein Cell, 2025, 16(3): 157-160 DOI:10.1093/procel/pwae053

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bekes M , Langley DR , Crews CM . PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 2022; 21: 181- 200.

[2]	Cao Y , Wang C , Zhang X . Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci Rep 2014; 4: 4965.

[3]	Casamayor A , Morrice NA , Alessi DR . Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 1999; 342: 287- 292.

[4]	Fu L , Cui CP , Zhang X . The functions and regulation of Smurfs in cancers. Semin Cancer Biol 2020; 67: 102- 116.

[5]	Gagliardi PA , Puliafito A , Primo L . PDK1: at the crossroad of cancer signaling pathways. Semin Cancer Biol 2018; 48: 27- 35.

[6]	Ghosh DK , Ranjan A . HYPK coordinates degradation of polyneddylated proteins by autophagy. Autophagy 2022; 18: 1763- 1784.

[7]	Han X , Sun Y . PROTACs: a novel strategy for cancer drug discovery and development. MedComm 2023; 4: e290.

[8]	He Y , Sun MM , Zhang GG . Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 2021; 6: 425.

[9]	Lazaro-Camp VJ , Salari K , Meng X . SETDB1 in cancer:overexpression and its therapeutic implications. Am J Cancer Res 2021; 11: 1803- 1827.

[10]	Peng Z , Fang W , Wu B . Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. Nat Chem Biol 2025; 21: 59- 70.

[11]	Xia Q , Li Y , Han D . SMURF1, a promoter of tumor cell progression? Cancer Gene Ther 2021; 28: 551- 565.

[12]	Xie P , Zhang M , He S . The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nat Commun 2014; 5: 3733.

[13]	Yamashita M , Ying SX , Zhang GM . Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005; 121: 101- 113.

[14]	Zhang Y , Wang C , Cao Y . Selective compounds enhance osteoblastic activity by targeting HECT domain of ubiquitin ligase Smurf1. Oncotarget 2017; 8: 50521- 50533.